Change at the top for Biogen after Alzheimer’s drug flops
Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer’s drug Aduhelm less than a year after ...
Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer’s drug Aduhelm less than a year after ...
Biogen expects “minimal” revenue this year from its Alzheimer’s treatment initially hailed as potentially a breakthrough drug, but one with ...
Shares of Biogen slid Wednesday, a day after federal regulators slapped coverage limitations on the drugmaker’s new Alzheimer’s disease treatment. ...
A US hospital on Wednesday gave the first infusion of an expensive, controversial new Alzheimer's drug from Biogen Inc before ...
Top News in World: Read Latest News on Sports, Business, Entertainment, Blogs and Opinions from leading columnists.